Renita Medical raises seed funding
Renita Medical Oy, a health tech company, has received seed funding which provides it with resources to finalize development and bring it to commercial launch.
Renita Medical is building a personalized brain health solution. The company’s AI-based software, the RENITA platform, uses a patient’s own functional brain activity and combines it with proven cognitive assessment tools to provide a comprehensive and objective report, from which doctors can base their neurological diagnosis. The platform will enhance the neurological diagnosis process and will offer an efficient way to monitor brain health.
Oaklins’ team in Finland acted as the financial advisor for the round.
Talk to the deal team
Related deals
Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreAmcomri Group has completed an initial public offering
Amcomri Group plc has successfully completed an initial public offering (IPO) on the AIM Market of the London Stock Exchange, successfully raising US$15 million (£12 million) through a placing. The IPO will enable Amcomri to further its ‘Buy-Improve-Build’ strategy in the UK engineering sector.
Learn more